Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

Autor Reis, Alessandra Diehi Autor UNIFESP Google Scholar
Castro, Luiz Andre Autor UNIFESP Google Scholar
Faria, Roberta Autor UNIFESP Google Scholar
Laranjeira, Ronaldo Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: To evaluate anticraving action and tolerability of topiramate in cocaine user treatment. Method: Male users of inhaled cocaine which met criteria for cocaine dependence (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) were selected for outpatient 12-week, open label trial with topiramate; individual dosage ranged between 25-300 mg/day. Main clinical variables were abstinence rate, craving intensity, frequency and duration, adherence, dropouts, side effects and impulsivity measure through Barratt Impulsivity Scale. Patients received assertive strategic counseling for abstinence assistance and medication monitoring evaluation every two weeks. Comparative analysis was made with intention to treat, missing values were replaced (last observation carried forward), and significance level was 5%. Results: Adherence to treatment was 57% (at least three evaluations), 32% dropped out (one evaluation). There were no severe side effects. Negative test average was 25.4% (31.2). Significant reduction in craving intensity and duration was observed in 25% of the sample. No statistical significant reduction in craving frequency was observed in 7.1%. Increase in frequency was observed in 10.7% and 82.1% did not present any variation. No significant statistical variations in Barratt Impulsivity Scale or in the total score were found in the final evaluation when compared to baseline. Conclusion: More randomized placebo-controlled trials with topiramate for cocaine dependants should be performed to evaluate preliminary evidence.
Assunto cocaine-related disorders
behavior, addictive
topiramate
clinical trial [publication type]
clinical protocols
Idioma Inglês
Data 2008-06-01
Publicado em Revista Brasileira de Psiquiatria. São Paulo: Assoc Brasileira Psiquiatria, v. 30, n. 2, p. 132-135, 2008.
ISSN 1516-4446 (Sherpa/Romeo, fator de impacto)
Editor Assoc Brasileira Psiquiatria
Extensão 132-135
Fonte http://dx.doi.org/10.1590/S1516-44462008005000012
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000256840100007
SciELO S1516-44462008005000012 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/30682

Mostrar registro completo




Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)

Buscar DSpace


Navegar

Minha conta